International experience and enlightenment of short-term payment for innovative medical technology under the DRG payment
10.3760/cma.j.cn111325-20220525-00475
- VernacularTitle:创新医疗技术DRG短期支付的国际经验及启示
- Author:
Yanhong HUANG
1
;
Jiayi GUO
;
Hongyi ZHANG
;
Jianlie YUAN
;
Junlong ZHANG
;
Ni JIN
Author Information
1. 浙江大学医学院附属金华医院，金华 321000
- Keywords:
Diagnosis-related groups;
Innovative medical technology;
Short-term payment;
Cost threshold;
High-value innovative drugs
- From:
Chinese Journal of Hospital Administration
2022;38(9):649-652
- CountryChina
- Language:Chinese
-
Abstract:
China has entered the task stage of comprehensive medical insurance payment reform, but there are problems restricting the development of innovative medical technology in the reform of diagnosis-related groups(DRG) payment system. The author introduced the international definition and scope of innovative medical technology, and summarized the preconditions and payment policy of short-term payment of innovative medical technology under the DRG payment system; And put forward suggestions in line with China′s actual situation, including clarifying the definition of innovative medical technology, setting access conditions for additional payment or actual payment, setting up special transition funds for high-value innovative drugs, clarifying the payment amount of innovative medical technology, and formulating payment strategies for innovative medical technology.
